| Utilize sequencing data as it pertains to identification and implementation of targeted therapeutics. |  |  |  |  |  | 
 | Utilize sequencing data as it pertains to identification and implementation of clinical trials. |  |  |  |  |  | 
 | Demonstrate understanding of genetic predisposition to cancer. |  |  |  |  |  | 
 | Integrate principles of germline and somatic molecular sequencing of patients' germline and tumor samples. |  |  |  |  |  | 
 | Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). |  |  |  |  |  |